ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disease Activity"

  • Abstract Number: 136 • 2016 ACR/ARHP Annual Meeting

    The 7-Joints Musculoskeletal Ultrasound Score (US7 score) Predicts Therapeutic Change in Patients with Early Rheumatoid Arthritis

    Sarah Ohrndorf1, Philipp Daniel Oberdorfer2, Lien Le3, Ulrich Mansmann3, Lisa Ines Sprenger2, Thomas Häupl4, Sandra Hermann2, Gabriela Schmittat2, Silvia Pade2, GR Burmester5, Anne-Marie Glimm2 and Marina Backhaus6, 1Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany, 2Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany, 3Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität Munich, Munich, Germany, 4Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany, 5Charité – University Medicine Berlin, Berlin, Germany, 6Department of Rheumatology & Immunology, University Medicine Charit, Berlin, Germany

    Background/Purpose: Treatment decisions in patients with Rheumatoid Arthritis (RA) after the “Treat to Target (T2T)” - principle is widely recommended, as this management strategy leads…
  • Abstract Number: 527 • 2016 ACR/ARHP Annual Meeting

    The Summed Bilateral Elbow Extension Angle in Rheumatoid Arthritis Correlates with the DAS28-CRP(4) and May be an Independent Marker of Bad Prognosis

    John P. Case1, Congbin Wang2 and Heidi Tucker3, 1Internal Medicine/Rheumatology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, 2Internal medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, 3Rush Medical College, Chicago, IL

    Background/Purpose: The elbow is an easily-examined joint and an important determinant of morbidity in rheumatoid arthritis (RA).  In active RA the measured elbow extension angle,…
  • Abstract Number: 787 • 2016 ACR/ARHP Annual Meeting

    Using the American College of Rheumatology and Systemic Lupus International Collaborating Clinics Criteria to Measure Disease Severity in Discoid Lupus Erythematosus

    Jenna K. Presto1,2, Jessica S. Haber1,2 and Victoria P. Werth1,2, 1Department of Dermatology, University of Pennsylvania, Philadelphia, PA, 2Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

    Background/Purpose: Discoid lupus erythematosus (DLE) progresses to systemic lupus erythematosus (SLE) in up to 28% of cases. The Systemic Lupus International Collaborating Clinics (SLICC) SLE…
  • Abstract Number: 1361 • 2016 ACR/ARHP Annual Meeting

    The Role of Von Willebrand Factor Antigen As a Disease Biomarker in the Clinical Assessment of Children with Juvenile Dermatomyositis

    Dawn Wahezi1, Vito Arena2, Jaeun Choi2 and Qi Gao2, 1Pediatric Rheumatology, The Children's Hospital at Montefiore, Bronx, NY, 2Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose:  With the advent of new therapies, outcomes for children with juvenile dermatomyositis (JDM) have significantly improved. Accurate markers of clinically inactivedisease are thus fundamental…
  • Abstract Number: 1526 • 2016 ACR/ARHP Annual Meeting

    Serum  y-Neuropeptide Levels and Its Relationship with Body Fat Mass and Clinical Characteristics in Rheumatoid Arthritis

    Melissa Ramirez-Villafaña1, Paulina Hernandez-Cuervo2, Ana Miriam Saldaña-Cruz3, Edsaul Emilio Perez-Guerrero4,5, Nicte Selene Fajardo-Robledo6, Edy David Rubio-Arellano7, Alejandra Flores-Chavez8, Javier Alejandro Aceves-Aceves9,10, Arnulfo Hernan Nava-Zavala11, Mario Salazar-Paramo12, Miguel Huerta13, Miriam Fabiola Alcaraz-Lopez14, Jorge Ivan Gamez-Nava15 and Laura Gonzalez-Lopez16, 1Departamento Medicina Interna-Reumatología, Instituto Mexicano del Seguro Social, Hospital General Regional 110, Jalisco, Mexico, 2Programa de Doctorado en Ciencias de la Salud Pública, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara. Guadalajara, Jalisco, México., Guadalajara, Mexico, 3Centro Universitario de Investigación Biomédica. Universidad de Colima, Colima, Mexico, 4Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Jalisco, Mexico, 5Doctorado en Farmacología, Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Jalisco, Mexico, 6Laboratorio de Investigación y Desarrollo Farmacéutico, Universidad de Guadalajara, Centro Universitario de Ciencias Exactas e Ingenierias, Jalisco, Mexico, 7Centro Universitario de Investigación Biomédica. Universidad de Colima., Colima, Colima, Mexico, 8Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Jalisco, Mexico, 9Departamento de Medicina Interna-Reumatologia, Hospital General Regional 110, IMSS, Guadalajara, Jalisco, Mexico, 10Posgrado de Farmacología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara., Guadalajara, Jalisco, Mexico, 11Unidad de Investigación Biomédica 02 (Unidad de Investigación en Epidemiología Clínica), UMAE, Hospital de Especialidades Centro Médico Nacional de Occidente, IMSS, Jalisco, Mexico, 12Physiology, HSC, University of Guadalajara, Guadalajara, Mexico, 13Centro Universitario de Investigación Biomédica, Universidad de Colima, Colima, Mexico, 14Departamento Medicina Interna-Reumatología, Instituto Mexicano del Seguro Social, Hospital General Regional 45, Jalisco, Mexico, 15Rheumatology, Centro Medico de Occidente, Guadalajara Jal, Mexico, 16Departamento de Medicina Interna/Rheumatología, Hospital General Regional 110, Instituto Mexicano del Seguro Social (IMSS), Guadalajara, Jalisco, Mexico

    Background/Purpose: Overweight and obesity are comorbidities that may increase the risk of cardiovascular disease in rheumatoid arthritis. Increase in in body fat is observed in…
  • Abstract Number: 1795 • 2016 ACR/ARHP Annual Meeting

    Four Years Follow-up of Subclinical Atherosclerosis in Systemic Lupus Erythematosus Patients

    Ju-Yang Jung1, Hyoun-Ah Kim1 and Chang-Hee Suh2, 1Department of Rheumatology, Ajou University School of Medicine, Suwon, South Korea, 2Department of Rheumatology, Ajou University School of Medicine, Suwon, Korea, The Republic of

    Background/Purpose: We assessed carotid artery intima-media thickness (cIMT) and carotid plaque by Doppler ultrasonography among sixty-one female SLE patients who were enrolled in the previous…
  • Abstract Number: 2444 • 2016 ACR/ARHP Annual Meeting

    Effects of Disease Activity and Drug Exposure on Pregnancy Outcomes with Inflammatory Arthritis

    Emily Fishman1, Kathryn H. Dao2 and John J. Cush3, 1Texas A&M HSC College of Medicine, Dallas, TX, 2Texas Health, Dallas, TX, 3Baylor Research Institute, Dallas, TX

    Background/Purpose: Pregnancy is often encountered in women who have inflammatory arthritis (IA), such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), juvenile arthritis (JIA) or ankylosing…
  • Abstract Number: 2624 • 2016 ACR/ARHP Annual Meeting

    Anti-Citrullinated Protein Antibodies Titers Are Independently Modulated By Disease Activity and Synthetic or Biologic Dmards in a Seropositive Early Arthritis Population

    Elena García Lorenzo1, Daniel Useros2, Aranzazu Alfranca3, Ana M. Ortiz Garcia1, Pablo Moreno Fresneda1, Isidoro Gonzalez-Alvaro1 and Rosario García-Vicuña1, 1Rheumatology, Rheumatology Service, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain, 2Rheumathology, Rheumatology Service, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain, 3Immunology, Immunology Service, Hospital Universitario de La Princesa, IIS-IP, Madrid, Spain

    Background/Purpose: Early introduction of some biologic (b) DMARDs has been proposed to reduce anti-citrullinated protein antibodies (ACPA) titers in clinical trials settings. However, less information…
  • Abstract Number: 2822 • 2016 ACR/ARHP Annual Meeting

    Serum 25-Hydroxyvitamin D3 Levels and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis

    Chi Chiu Mok1, Eric Bro2, Ling Yin Ho3, Ravinder Singh2 and Paul Jannetto4, 1Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong, 2Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 3Dept of Medicine, Tuen Mun Hospital, Hong Kong SAR, Hong Kong, 4Director, Toxicology and Drug Monitoring Laboratory, Mayo Clinic, Rochester, MN

    Background/Purpose: To study the relationship between serum 25-hydroxyvitamin D3 levels and flares of systemic lupus erythematosus (SLE) in a longitudinal cohort of Chinese patients. Methods:…
  • Abstract Number: 3106 • 2016 ACR/ARHP Annual Meeting

    A Simple Test for Assessing and Monitoring SLE Disease Activity Status

    Chaim Putterman1, Michael Rowe2, Joseph Barten Legutki2, Theodore M. Tarasow2 and Kathryn Sykes2, 1Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, 2HealthTell, Inc, san ramon, CA

    Background/Purpose: SLE patients can experience chronically active disease, remissions and flares, or long periods of quiescence. Accurately assessing disease activity is crucial for prescribing appropriate…
  • Abstract Number: 160 • 2016 ACR/ARHP Annual Meeting

    Ultrasound Assessment of Rheumatoid Arthritis Patients. External Validation and Inter-Rater Reliability of a 4-Joint Ultrasonographic Scoring System

    Tomas Cazenave1, María Victoria Martire2,3, Christian A. Waimann4,5, Javier Rosa6, Marcelo Audisio7, Ana Bertoli8, Guillermo Py9, Santiago Ruta6, Josefina Marin10, Johana Zacariaz6, Cristian Troitiño11, Mariana Benegas12, Lida Santiago13, Patricio Tate14, Walter J. Spindler15, Horacio Berman16, María Julia Santa Cruz17, Paula Kohan18, Silvia Beatriz Papasidero19, Gustavo Citera20 and Marcos G. Rosemffet1, 1Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 3Rheumatology, Hospital Italiano de La Plata, La Plata, Argentina, 4Escuela Superior de Ciencias de la Salud, UNICEN., Olavarria,, Argentina, 5Rheumatology, Hospital Dr. Hector Cura, Olavarria, Argentina, 6Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 7Servicio de Reumatología del Hospital Nacional de Clínicas, Córdoba, Argentina, 8Instituto Reumatológico Strusberg, Córdoba, Argentina, 9Servicio de Reumatología del Hospital Nacional de Clínicas, Córdoba., Cordoba, Argentina, 10Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 11Reumatologia, Hospital Bernardino Rivadavia, CAPITAL FEDERAL, Argentina, 12PSORIAHUE, Buenos Aires, Argentina, 13Organizacion Medica de Investigacion, Buenos Aires, Argentina, 14Organizacion Médica de Investigación, Buenos Aires, Argentina, 15Centro Médico Privado de Reumatología, Tucuman, Argentina, 16Centro Médico Privado de Reumatología, Tucumán, Argentina, 17Hospital Dr. E. Tornú, Buenos Aires, Argentina, 18Hospital Dr. E. Tornu, Buenos Aires, Argentina, 19Rheumatology Department, Rheumatology Unit, Hospital General de Agudos Dr. E. Tornú, Buenos Aires, Argentina, 20Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina

    Background/Purpose: Although Ultrasound (US) has demonstrated to be a sensitive and specific tool, its feasibility in daily clinical practice is still under debate. We have…
  • Abstract Number: 529 • 2016 ACR/ARHP Annual Meeting

    The Relationship Between Promis and CDAI Scores, Disease Duration, Age and Gender in Patients with Rheumatoid Arthritis

    Alicia Lieberman1, Judith Baumhauer2, Chris Dasilva2 and Allen P. Anandarajah3, 1Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 2Orthopedic surgery, University of Rochester Medical Center, Rochester, NY, 3Dept of Rheumatology, Univ of Rochester Medical Ctr, Rochester, NY

    Background/Purpose:   PROMIS (Patient-Reported Outcomes Measurement Information System) is a self-reported and parent-reported measure of global, physical, mental, and social health for the general population…
  • Abstract Number: 794 • 2016 ACR/ARHP Annual Meeting

    Development and Initial Validation of a Novel Lupus Disease Activity Index to Account for Glucocorticoids: Sledai-2K Glucocorticoids Index (SGI)  

    Zahi Touma1, Dafna D Gladman2, Jiandong Su3 and Murray Urowitz1, 1Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada

    Background/Purpose:  It is challenging to describe disease activity in SLE in the context of multiple levels of glucocorticoids (GC) treatment. We aim to develop and…
  • Abstract Number: 1367 • 2016 ACR/ARHP Annual Meeting

    Long-Term Outcomes and Their Predictors in Patients with Juvenile Idiopathic Inflammatory Myopathies of Adult Age: A Referral Population Study

    Sam Serafi1, Vladislav Tsaltskan2, Anna Yakovleva3, Heidi Sami1, Frederick W. Miller4, Rodolfo Curiel1, Olcay Y. Jones1,5 and Lisa G. Rider1,4, 1Rheumatology, George Washington University, Washington, DC, 2Internal Medicine, George Washington University, Washington, DC, 3Department of Microbiology, Immunology, and Tropical Medicine., George Washington University, Washington, DC, 4Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, NIH, Bethesda, MD, 5Pediatrics, Walter Reed National Military Medical Center, Bethesda, MD

    Background/Purpose:  To investigate the long-term outcomes and prognostic factors for pts with juvenile-onset idiopathic inflammatory myopathies (JIIM) who are currently adults. Methods: Adults with JIIM…
  • Abstract Number: 1538 • 2016 ACR/ARHP Annual Meeting

    Lower Ratings of Pain Intensity in Older Adults Lead to Underestimation of Disease Activity By Disease Activity Score 28-C-Reactive Protein (DAS28-CRP) in Patients with Rheumatoid Arthritis

    Yong Gil Hwang1, Juan (June) Feng2, Heather Eng2, Jason Lyons2, Anthony Fabio2 and Larry W. Moreland1, 1Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 2Epidemiology, University of Pittsburgh, School of Public Health, Pittsburgh, PA

    Background/Purpose:   To investigate the influence of age on the components of the 28-joint Disease Activity Score (DAS28)-C-reactive protein (CRP) in patients with rheumatoid arthritis…
  • « Previous Page
  • 1
  • …
  • 70
  • 71
  • 72
  • 73
  • 74
  • …
  • 102
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology